Xeris Biopharma Holdings Inc (XERS)
3.085
+0.04
(+1.48%)
USD |
NASDAQ |
Nov 22, 12:54
Xeris Biopharma Holdings Price: 3.085 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 21, 2024 | 3.08 | 3.12 | 3.03 | 3.04 | 1.296M |
| Nov 20, 2024 | 2.99 | 3.075 | 2.96 | 3.06 | 1.065M |
| Nov 19, 2024 | 2.86 | 3.01 | 2.86 | 3.01 | 783921.0 |
| Nov 18, 2024 | 2.91 | 2.93 | 2.82 | 2.90 | 1.416M |
| Nov 15, 2024 | 3.07 | 3.07 | 2.91 | 2.92 | 1.924M |
| Nov 14, 2024 | 3.15 | 3.16 | 3.04 | 3.05 | 1.478M |
| Nov 13, 2024 | 3.20 | 3.325 | 3.15 | 3.15 | 2.434M |
| Nov 12, 2024 | 3.25 | 3.27 | 3.025 | 3.15 | 3.685M |
| Nov 11, 2024 | 3.43 | 3.43 | 3.21 | 3.28 | 2.427M |
| Nov 08, 2024 | 3.40 | 3.64 | 3.06 | 3.47 | 6.684M |
| Nov 07, 2024 | 3.34 | 3.415 | 3.28 | 3.36 | 2.582M |
| Nov 06, 2024 | 3.31 | 3.39 | 3.25 | 3.34 | 2.341M |
| Nov 05, 2024 | 3.25 | 3.280 | 3.10 | 3.26 | 1.474M |
| Nov 04, 2024 | 3.20 | 3.315 | 3.13 | 3.22 | 1.186M |
| Nov 01, 2024 | 3.26 | 3.290 | 3.171 | 3.23 | 686782.0 |
| Oct 31, 2024 | 3.22 | 3.29 | 3.10 | 3.22 | 1.706M |
| Oct 30, 2024 | 3.25 | 3.31 | 3.19 | 3.23 | 1.007M |
| Oct 29, 2024 | 3.21 | 3.25 | 3.15 | 3.23 | 968915.0 |
| Oct 28, 2024 | 3.25 | 3.349 | 3.21 | 3.23 | 1.327M |
| Oct 25, 2024 | 3.25 | 3.39 | 3.195 | 3.20 | 2.169M |
| Oct 24, 2024 | 3.10 | 3.27 | 3.08 | 3.24 | 1.850M |
| Oct 23, 2024 | 2.99 | 3.115 | 2.963 | 3.11 | 1.238M |
| Oct 22, 2024 | 3.00 | 3.09 | 2.98 | 3.02 | 763681.0 |
| Oct 21, 2024 | 3.04 | 3.085 | 2.98 | 3.03 | 1.056M |
| Oct 18, 2024 | 3.04 | 3.116 | 3.025 | 3.06 | 936645.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.03
Minimum
Jan 05 2023
9.00
Maximum
Dec 10 2019
2.949
Average
2.45
Median
Sep 30 2021
Price Benchmarks
| Zevra Therapeutics Inc | 9.58 |
| NovaBay Pharmaceuticals Inc | 0.6946 |
| Palatin Technologies Inc | 0.9605 |
| iBio Inc | 2.68 |
| Theriva Biologics Inc | 1.30 |
Price Related Metrics
| PS Ratio | 2.371 |
| Earnings Yield | -14.26% |
| Market Cap | 459.92M |